GlaxoSmithKline awards $1.5 billion media account to Publicis Media
The account was won following a media review which began in May this year
Published - 22-November-2018
Pharmaceutical giant GlaxoSmithKline (GSK) has awarded its $1.7 billion media business to Publicis Media, following a review which began in May this year, according to media reports.
It has been reported that Publicis Media has created a dedicated unit to handle the account.
According to reports, Scott Grenz, VP of Consumer Healthcare and Global Head of Media, GlaxoSmithKline, said in an updated statement, "We ran a very thorough and competitive pitch process with strong presentations from all companies, but ultimately Publicis was the best fit for us. We’re excited about the new partnership and the potential of the platformGSK model as we continue to progress our marketing transformation program."
The 'platformGSK' model will synergise various expertise from across Publicis Media in the areas of healthcare, consumer strategy and digital business transformation.
The review, which was handled by ID Comms, came less than three years after MediaCom won GSK's European business, while PHD will handle the US media mandate. Both agencies had retained the accounts in 2015 following a global media review, after initially winning the account in 2013.For more updates, subscribe to exchange4media's WhatsApp Channel- https://bit.ly/2QUdLCK